2021-01-07,Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
2020-12-28,Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
2020-12-23,SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Endpoint
2020-12-22,"The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes"
2020-12-22,Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
2020-12-16,Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
2020-12-08,Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
2020-11-17,"Pfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenix's Civax (TM) May Be a Better Alternative"
2020-11-16,SNGX: One Positive Phase 3 Clinical Trial; One More to Readout Before End of 2020
2020-11-12,How Much Did Soligenix's(NASDAQ:SNGX) Shareholders Earn From Share Price Movements Over The Last Five Years?
2020-11-12,"Soligenix, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th"
2020-11-12,Soligenix Announces Recent Accomplishments And Third Quarter 2020 Financial Results
2020-11-10,Soligenix Invited to Present at Upcoming Virtual Investor Conferences
2020-10-23,SNGX: Cycle 3 Data for SGX301 Phase 3 Trial in CTCL Shows Continued Positive Effects
2020-10-22,Why Soligenix's Stock Is Trading Higher Today
2020-10-22,Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma
2020-10-08,Soligenix to Present at the BIO Investor Forum
2020-09-21,Soligenix's RiVax(R) Program Back in Focus After Deadly Ricin Toxin Intercepted Before Reaching White House
2020-09-15,Soligenix Announces Publication Demonstrating Thermostabilization of Filovirus Vaccine Antigens
2020-09-11,SNGX: Update and Q&A on COVID-19 Vaccine Candidate CiVax
2020-09-10,Soligenix Announces Investor Webcast Event and Presentation Today: Advantages of the CiVax Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
2020-09-09,Soligenix Invited to Present at Upcoming Virtual Investor Conferences
2020-09-03,How Much Is Soligenix's (NASDAQ:SNGX) CEO Getting Paid?
2020-09-03,Soligenix Announces Investor Webcast Event: Advantages of the CiVax Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine
2020-08-27,Soligenix to Present at the LD Micro Conference
2020-08-17,SNGX: Multiple Upcoming Catalysts
2020-08-14,Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results
2020-08-12,"INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Soligenix, Inc. for Potential Breach of Fiduciary Duty Claims"
2020-07-28,Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine
2020-07-20,Soligenix Issues Corporate Update - Highlights Important Catalysts for Second Half of 2020
2020-06-30,SNGX: Q&A with Dr. Straube Regarding the Phase 3 OM Trial
2020-06-26,Why Soligenix's Stock Is Trading Higher Today
2020-06-26,"Soligenix, Inc. (NASDAQ:SNGX) Analysts Just Slashed This Year's Revenue Estimates By 36%"
2020-06-24,Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
2020-06-22,Soligenix to Join Russell Microcap® Index
2020-06-22,SNGX: Q&A on COVID-19 Vaccine Candidate CiVax
2020-06-09,Soligenix to Present at the MedInvest Infectious Disease and Immunology Investor Conference
2020-05-28,"How Hedge Funds Traded Soligenix, Inc. (SNGX) During The Crash"
2020-05-20,SNGX: Publication on Immune Correlates for RiVax®
2020-05-17,"What You Must Know About Soligenix, Inc.'s (NASDAQ:SNGX) Beta Value"
2020-05-15,Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
2020-05-11,Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
2020-05-07,"Soligenix Receives $840,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program"
2020-05-05,SNGX: Continued Treatment with SGX301 Leads to Increased Efficacy in CTCL
2020-04-30,Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
2020-04-16,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant"
2020-04-16,Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals
2020-04-06,Soligenix Receives European Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
2020-04-01,"Soligenix, Inc. (NASDAQ:SNGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know"
2020-03-31,SNGX: Developing Coronavirus Vaccine
2020-03-30,Soligenix Announces Recent Accomplishments And Year-End 2019 Financial Results
2020-03-24,Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share
2020-03-23,Soligenix and University of Hawaii at Mnoa Initiate Work on Novel Coronavirus Vaccine for COVID-19
2020-03-23,SNGX: Positive Results for Phase 3 CTCL Trial
2020-03-20,"Soligenix, Inc. Impresses With Statistically Significant Topline Phase 3 Data From SGX301 FLASH Trial; Targets $250 Million CTCL Patient Market"
2020-03-19,Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
2020-02-27,Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform
2020-02-20,"Independent Case Study For Soligenix's CTCL Drug, SGX301, Drives Bullish Sentiment; Topline ""FLASH"" Trial Data Expected Q1 2020"
2020-02-18,"SNGX: KOL Interview with Dr. Brian Poligone,  an Investigator in P3 FLASH Study in CTCL"
2020-02-13,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO"
2020-02-13,"FDA Grants Soligenix ""Fast Track"" Designation for RiVax® in the Prevention of Ricin Poisoning"
2020-02-11,Soligenix Announces SGX301 Patient Case Study Presentation at the 4th World Congress of Cutaneous Lymphomas
2020-02-03,Soligenix Announces Japanese Patent Allowance for Use of Dusquetide in Oral Mucositis
2020-01-30,Soligenix Stock Jumps 95% YTD Ahead of Topline Data Release For SGX301; Targeting $250 Million Unmet Market Opportunity To Treat CTCL
2020-01-30,Soligenix to Present at the 22nd Annual BIO CEO & Investor Conference
2020-01-28,Is Soligenix (NASDAQ:SNGX) In A Good Position To Deliver On Growth Plans?
2020-01-16,Soligenix Shares Power Higher Ahead of SGX301 Phase 3 Data Release; Projected $200 Million Revenue Opportunity For CTCL Drug
2020-01-06,SNGX: Interview with Dr. Straube Regarding the Upcoming Phase 3 CTCL Data Readout
2019-12-20,"How Much is Soligenix, Inc.'s (NASDAQ:SNGX) CEO Getting Paid?"
2019-12-18,"Soligenix to Receive $850,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program"
2019-12-13,CORRECTION FROM SOURCE: Major Milestones for Soligenix Bring 2019 to a Strong Close
2019-12-12,Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
2019-12-11,Major Milestones for Soligenix Bring 2019 to a Strong Close
2019-12-05,SNGX: CTCL Phase 3 Trial Fully Enrolled; Data in 1Q20
2019-12-03,Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX301 in the Treatment of Cutaneous T-cell Lymphoma
2019-11-18,Soligenix to Present at the PCG Spotlight Series Conference
2019-11-14,"If You Had Bought Soligenix (NASDAQ:SNGX) Stock Five Years Ago, You'd Be Sitting On A 94% Loss, Today"
2019-11-14,SNGX: Two Phase 3 Data Readouts Over the Next Two Quarters
2019-11-12,Soligenix Announces Recent Accomplishments And Third Quarter 2019 Financial Results
2019-11-06,Soligenix to Present at the 25th Annual BIO-Europe International Partnering Conference
2019-10-24,Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
2019-10-22,Catalyst Watch: Soligenix Inc.'s SGX301 and SGX942 Upcoming Data Release Can Change the CTCL and Oral Mucositis Treatment Landscape
2019-10-03,Soligenix's SGX942 On Track To Fill Unmet Medical Need; Targeting Oral Mucositis In Patients With Head and Neck Cancer
2019-10-03,"Soligenix to Present at the 20th Annual GCFF Investor Conference in Vancouver, British Columbia, Canada"
2019-09-16,Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
2019-09-11,Soligenix Appoints Jonathan Guarino as Chief Financial Officer
2019-08-29,Soligenix to Present at the RHK Capital 2019 Disruptive Growth Conference
2019-08-28,SNGX: Q&A on SGX942 Phase 3 Trial Interim Analysis
2019-08-28,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved"
2019-08-28,SNGX: Q&A on SGX942 Phase 3 Trial Interim Analysis
2019-08-28,Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
2019-08-22,SNGX: Interim Analysis for Phase 3 Oral Mucositis Trial Imminent
2019-08-15,Moleculin Completes Enrollment in Early-Stage Cancer Study
2019-08-15,"Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications"
2019-08-13,Soligenix Announces Recent Accomplishments And Second Quarter 2019 Financial Results
2019-08-01,SNGX: What to Expect from the Upcoming Interim Analysis of SGX942
2019-07-31,Soligenix Announces Conference Presentations Demonstrating Formulations of Single and Multivalent Ebola Subunit Vaccines
2019-07-29,"Potential Near Term Catalyst For Soligenix Approaches; Interim Analysis For SGX942, DOM-INNATE Trial Expected In September (NasdaqCM: SNGX)"
2019-07-29,Soligenix Receives European Patents for Oral BDP in the Treatment of Acute Radiation Injury of the Gastrointestinal Tract
2019-07-15,Soligenix Inc's.(NASDAQ: SNGX) Two Late-Stage Phase III Trials Can Deliver A $500 Million Catalyst
